VAMP, a tetrapeptide, is a competitive dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 1.00 µM and a Kd of 6.89 µM. VAMP effectively targets the DPP-IV-GLP-1 axis and can be used for the study of type 2 diabetes[1].
Molecular Weight:
416.54
Purity:
98.13
Formula:
C18H32N4O5S
Target:
Dipeptidyl Peptidase
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
